In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

The extant literature elucidates treatment targets for cognitive and psychosocial
interventions. Research using longitudinal, prospective study designs is needed to …

Simple Summary The coronavirus can elude the immune response, potentially spreading to
cells other than the respiratory tract's epithelial cells. The neuro-invasive potential of certain …

Background: Persistent coronavirus disease 2019 (COVID-19) symptoms are increasingly
well-reported in cohort studies and case series. Given the spread of the pandemic, number …

In December 2019 a novel coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), started spreading from Wuhan city …

Background COVID-19 survivors are predicted to experience the long-term consequences,
including pulmonary, neurologic, cardiovascular, and mental health sequelae. This …

Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge
determinant of prognosis during the acute phase of the disease. However, little is known …

Introduction and purpose of the study: SARS-CoV-2 virus does not only affect the respiratory
system. It may cause damage to many organ systems with long-term effects. The latest …

Older age is a major risk factor for adverse outcomes of COVID-19, potentially due to
immunosenescence and chronic low-grade inflammation, both characteristics of older adults …

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic by the World …